Adaptive changes in M1 muscarinic receptors localized to specific rostral brain regions during and after morphine withdrawal

Neuropharmacology

Volumn 39, Issue 10, 2000, Pages 1720-1731

  Zhang, Lu C ^a,b   Buccafusco, Jerry J ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Abstinence; Autoradiography; Cerebral cortex; Cholinergic receptors; Hippocampus; Morphine; Motor activity; Reverse transcriptase polymerase chain reaction; Withdrawal

Indexed keywords

MESSENGER RNA; MORPHINE; MUSCARINIC M1 RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG DEPENDENCE; FRONTAL CORTEX; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WITHDRAWAL SYNDROME;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BLOOD PRESSURE; BODY WEIGHT; BRAIN; ISOFLUROPHATE; MALE; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; PIRENZEPINE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TRITIUM;

EID: 0034047652     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00012-5     Document Type: Article

References (49)

1. Albin M.S., Orr M.D., Bunegin L., Henderson P.A. Tetrahydroaminoacridine antagonism to narcotic addiction. Experimental Neurology. 46:1975;644-648.
2. Araujo D.M., Collier B. Do presynaptic opiate receptors and alpha-adrenoceptors alter acetylcholine release from a sympathetic ganglion by a similar mechanism? European Journal of Pharmacology. 139:1987;179-186.
3. Buccafusco J.J. Participation of different brain regions in the anti-narcotic withdrawal action of clonidine in the dependent rat. Brain Research. 513:1990;8-14.
4. Buccafusco J.J. Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP). Life Sciences. 48:1991;749-756.
5. Buccafusco J.J. Neuropharmacologic and behavioral actions of clonidine: interactions with central neurotransmitters. International Review of Neurobiology. 33:1992;55-107.
6. Buccafusco J.J., Terry A.V. Jr., Shuster L. Spinal NMDA receptor-nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Research. 679:1995;189-199.
7. Buccafusco J.J., Zhang L.C., Prendergast M.A. Estimation of the mRNAs encoding the cholinergic muscarinic receptor and acetylcholine vesicular transport proteins involved in central cardiovascular regulation. Lydic R. Molecular Regulation of Arousal States. 1998;11-22 CRC Press, New York.
8. Buccafusco J.J., Zhang L.C., Shuster L.C., Jonnala R.R., Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Research. 852:2000;76-83.
9. Buckley N.J., Bonner T.I., Brann M.R. Localization of a family of muscarinic receptor mRNAs in rat brain. Journal of Neuroscience. 8:1988;4646-4652.
10. Carelli R.M., Deadwyler S.A. Cellular mechanisms underlying reinforcement-related processing in the nucleus accumbens: electrophysiological studies in behaving animals. Pharmacology Biochemistry and Behavior. 57:1997;495-504.
11. Casamenti F., Pedata F., Corradetti R., Pepeu G. Acetylcholine input from the cerebral cortex, choline uptake and muscarinic receptors in morphine-dependent, freely-moving rats. Neuropharmacology. 19:1980;597-605.
12. Caufield M.P. Muscarinic receptors - characterization, coupling and function. Pharmacology and Therapeutics. 58:1993;319-379.
13. Costa E., Cheney D.L., Racagni G., Zsilla G. An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions. Life Sciences. 17:1975;1-8.
14. Coutinho-Netto J., Abdul-Ghani A.S., Bradford H.F. Morphine suppression of neurotransmitter release evoked by sensory stimulation in vivo. Biochemical Pharmacology. 31:1982;1019-1023.
15. Cox B.M., Weinstock M. The effect of analgesic drugs on the release of acetylcholine from the electrically stimulated guinea-pig ileum. British Journal of Pharmacology. 27:1966;81-92.
16. Crossland J., Ahmed K.Z. Brain acetylcholine during morphine withdrawal. Neurochemical Research. 9:1984;351-366.
17. Domino E.F., Wilson A.E. Enhanced utilization of brain acetylcholine during morphine withdrawal in the rat. Nature. 243:1973;285-286.
18. Gattu M., Wei J., Pauly J.R., Urbanawiz S., Buccafusco J.J. Increased expression of M2 muscarinic receptor mRNA and binding sites in the rostral ventrolateral medulla of spontaneously hypertensive rats. Brain Research. 756:1997;125-132.
19. Gattu M., Wei J., Pauly J.R., Urbanawiz S., Buccafusco J.J. Autoradiographic comparison of muscarinic M1 and M2 binding sites in the CNS of spontaneously hypertensive and normotensive rats. Brain Research. 771:1997;173-183.
20. Grant S., London E.D., Newlin D.B., Villemagne V.L., Liu X., Contoreggi C., Philips R.L., Kimes A.S., Margolin A. Activation of memory circuits during cue-elicited cocaine craving. Proceedings of the National Academy of Science (USA). 93:1996;12040-12045.
21. Herz A. Opioid reward mechanisms: a key role in drug abuse? Canadian Journal of Physiology and Pharmacology. 76:1998;252-258.
22. Holland L.N., Shuster L.C., Buccafusco J.J. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat. Neuropharmacology. 32:1993;1387-1395.
23. Imperato A., Obinu M.C., Casu A., Mascia M.S., Carta G., Gessa G.L. Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. European Journal of Pharmacology. 302:1996;21-26.
24. Jhamandas K., Sawynok J., Sutak M. Enkephalin effects on release of brain acetylcholine. Nature. 269:1977;433-434.
25. Kennedy B.L., Wast T.C. Effect of morphine on electrically-induced release of autonomic mediators in the rabbit sinoatrial node. Journal of Pharmacology and Experimental Therapeutics. 157:1967;149-158.
26. Koob G.F. Hedonic valence, dopamine and motivation. Molecular Psychiatry. 1:1996;186-189.
27. Lapchak P.A., Araujo D.M., Collier B. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat. Neuroscience. 31:1989;313-325.
28. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. Journal of Neuroscience. 11:1991;3218-3226.
29. Marshall D.C., Buccafusco J.J. A comparison of the cardiovascular and the behavioral changes following naloxone as measures of the degree of physical dependence on morphine in rats. Drug Development Research. 5:1985;271-280.
30. Marshall D.C., Buccafusco J.J. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat. Journal of Neuroscience. 7:1987;621-628.
31. Moroni F., Cheney D.L., Costa E. The turnover rate of acetylcholine in brain nuclei of rats injected intraventricularly and intraseptally with alpha and beta-endorphin. Neuropharmacology. 17:1978;191-196.
32. Mulder A.H., Wardeh G., Hogenboom F., Frankhuyzen A.L. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-280.
33. Paton W.D. The action of morphine and related substances on the contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. British Journal of Pharmacology. 12:1957;119-127.
34. Pelikan E.W. The mechanism of ganglionic blockage produced by nicotine. Annals of the New York Academy of Sciences. 90:1960;52-69.
35. Prendergast M.A., Terry A.V. Jr., Buccafusco J.J. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology. 129:1997;183-191.
36. Racagni G., Cheney D.L., Zsilla G., Costa E. The measurement of acetylcholine turnover rate in brain structures. Neuropharmacology. 15:1976;723-736.
37. Rada P.V., Mark G.P., Taylor K.M., Hoebel B.G. Morphine and naloxone, IP or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacology Biochemistry and Behavior. 53:1996;809-816.
38. Redmond D.E., Krystal J.H. Multiple mechanisms of withdrawal from opioid drugs. Annual Review of Neuroscience. 7:1984;443-478.
39. Self D.W. Neural substrates of drug craving and relapse in drug addiction. Annals of Medicine. 30:1998;379-389.
40. Setlow B. The nucleus accumbens and learning and memory. Journal of Neuroscience Research. 49:1997;515-521.
41. Sharif S.I., el-Kadi A.O. The role of cholinergic systems in the expression of morphine withdrawal. Neuroscience Research. 25:1996;155-160.
42. 14C) acetylcholine from rat brain cortex slices. Journal of Pharmacy and Pharmacology. 21:1969;546-547.
43. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
44. Smith J.E., Co C., Lane J.D. Limbic acetylcholine turnover rates correlated with rat morphine-seeking behaviors. Pharmacology Biochemistry and Behavior. 20:1984;429-442.
45. Vasko M.R., Domino E.F. Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat. Journal of Pharmacology and Expimental Therapeutics. 207:1978;848-958.
46. Wei J., Milici A., Buccafusco J.J. Alterations in the expression of the genes encoding specific muscarinic receptor subtypes in the hypothalamus of spontaneously hypertensive rats. Circulation Research. 76:1995;142-146.
47. Wei J., Walton E.A., Milici A., Buccafusco J.J. M1-M5 Muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. Journal of Neurochemistry. 63:1994;815-882.
48. Yang G., Zhou W., Zhang F. Experimental study of selective muscarinic receptor antagonists on attenuation of morphine tolerance and dependence in rats. Chinese Medical Journal. 77:1997;130-133.
49. Zhang L.C., Buccafusco J.J. Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms. Brain Research. 803:1998;114-121.